MTAP-DELETED NSCLC

Clinical trials for MTAP-DELETED NSCLC explained in plain language.

Never miss a new study

Get alerted when new MTAP-DELETED NSCLC trials appear

Sign up with your email to follow new studies for MTAP-DELETED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug targets genetic weakness in Tough-to-Treat lung cancer

Disease control Recruiting now

This study is testing an experimental drug called AMG 193 for people with advanced non-small cell lung cancer that has a specific genetic change (MTAP-deleted) and has worsened after at least one prior treatment. The main goals are to see if the drug shrinks tumors, how long the …

Matched conditions: MTAP-DELETED NSCLC

Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

MTAP-DELETED NSCLC

Get alerted when new MTAP-DELETED NSCLC trials appear

New drug targets genetic weakness in Tough-to-Treat lung cancer